Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis

A Multicenter, Randomized, Double-blind, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R206 and Bonviva for the Improvement of Vitamin D in Postmenopausal Women With Osteoporosis

A multicenter, randomized, double-blind, active-controlled, phase III clinical trial to evaluate the efficacy and safety of Dp-R206 and Bonviva for 16 weeks once a month on the improvement of vitamin D in postmenopausal women with osteoporosis.

Inclusion Criteria:

• Female more than 40 years old in postmenopausal

Exclusion Criteria:

• Subject who has a history of malignant cancer